Full Text View
Tabular View
No Study Results Posted
Related Studies
Premature Coronary Atherosclerosis in Scleroderma
This study is currently recruiting participants.
Verified by Tuen Mun Hospital, May 2009
First Received: September 5, 2006   Last Updated: May 26, 2009   History of Changes
Sponsor: Tuen Mun Hospital
Information provided by: Tuen Mun Hospital
ClinicalTrials.gov Identifier: NCT00372398
  Purpose

The purpose of this trial is to study the proportion of scleroderma patients who suffer from asymptomatic coronary atherosclerosis compared to healthy controls.


Condition
Scleroderma

Study Type: Observational
Study Design: Case Control, Cross-Sectional
Official Title: Premature Coronary Atherosclerosis in Scleroderma: A Case Control Study

Further study details as provided by Tuen Mun Hospital:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 40
Study Start Date: October 2006
Estimated Study Completion Date: February 2010
Estimated Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Coronary calcium scores will be obtained from a group of patients with scleroderma and a group of controls. Comparison of the calcium scores will be made.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

scleroderma patients

Criteria

Inclusion Criteria:

  1. Age >= 18 years.
  2. Fulfillment of the American College of Rheumatology (ACR) criteria for the classification of scleroderma.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00372398

Contacts
Contact: CC Mok, MD, FRCP ccmok2006@gmail.com

Locations
Hong Kong
Tuen Mun Hospital Recruiting
Hong Kong, Hong Kong
Principal Investigator: Chi Chiu Mok, MD, FRCP            
Sponsors and Collaborators
Tuen Mun Hospital
Investigators
Principal Investigator: CC Mok, MD FRCP Tuen Mun Hospital, Hong Kong
  More Information

No publications provided

Responsible Party: Tuen Mun Hospital, Hong Kong ( CC Mok )
Study ID Numbers: NTWC/CREC/429/06
Study First Received: September 5, 2006
Last Updated: May 26, 2009
ClinicalTrials.gov Identifier: NCT00372398     History of Changes
Health Authority: Hong Kong: Ethics Committee

Keywords provided by Tuen Mun Hospital:
scleroderma
sclerosis
atherosclerosis

Additional relevant MeSH terms:
Scleroderma, Localized
Coronary Disease
Arterial Occlusive Diseases
Atherosclerosis
Heart Diseases
Skin Diseases
Myocardial Ischemia
Connective Tissue Diseases
Vascular Diseases
Cardiovascular Diseases
Arteriosclerosis
Coronary Artery Disease

ClinicalTrials.gov processed this record on February 08, 2010